(19)
(11) EP 0 491 844 A1

(12)

(43) Date of publication:
01.07.1992 Bulletin 1992/27

(21) Application number: 90914632.0

(22) Date of filing: 19.09.1990
(51) International Patent Classification (IPC): 
A61K 39/ 00( . )
A61P 37/ 00( . )
C07K 7/ 08( . )
C07K 14/ 16( . )
G01N 33/ 569( . )
A61K 39/ 21( . )
C07K 7/ 06( . )
C07K 14/ 00( . )
G01N 33/ 53( . )
(86) International application number:
PCT/US1990/005343
(87) International publication number:
WO 1991/004051 (04.04.1991 Gazette 1991/08)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB IT LI LU NL SE

(30) Priority: 19.09.1989 US 19890409596

(71) Applicants:
  • MEDIMMUNE, INC.
    Gaithersburg, MD 20878 (US)
  • UNITED STATES GOVERNMENT as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Bethesda, MD 20892 (US)

(72) Inventors:
  • FUERST, Thomas
    Gaithersburg, MD 20877 (US)
  • KOENIG, Scott
    Rockville, MD 20852 (US)

(74) Representative: Lord, Hilton David, et al 
MARKS & CLERK, 57-60 Lincoln's Inn Fields
London WC2A 3LS
London WC2A 3LS (GB)

   


(54) PEPTIDES INCLUDING CTL EPITOPES OF HIV PROTEINS AND USE THEREOF